FdaApplication
ANDA 207457
Identifiers
- fda_app_no: ANDA207457
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2018-02-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUMATRIPTAN AND NAPROXEN SODIUM | NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE | 500MG;EQ 85MG BASE | TABLET;ORAL |
1 product